首页> 外文期刊>Frontiers in Pharmacology >Fibroblast Growth Factors in Depression
【24h】

Fibroblast Growth Factors in Depression

机译:抑郁症中的成纤维细胞生长因子

获取原文
       

摘要

Major depressive disorder (MDD) is one of the most serious diseases and now becomes a major public health problem in the world. The pathogenesis of depression remains poorly understood. Fibroblast growth factors (FGFs) belong to a large family of growth factors that are involved in brain development during early periods as well as maintenance and repair throughout adulthood. In recent years, studies have found a correlation between the members of the FGF system and depression. These signaling molecules may be expected to be biomarkers for the diagnosis and prognosis of MDD, and may provide new drug targets for the treatment of depression. Here, we reviewed the correlation between some members of the FGF system and depression.
机译:严重抑郁症(MDD)是最严重的疾病之一,现已成为世界范围内的主要公共卫生问题。抑郁症的发病机理仍然知之甚少。成纤维细胞生长因子(FGFs)属于一大类生长因子,与早期的大脑发育以及整个成年期的维持和修复有关。近年来,研究发现FGF系统成员与抑郁症之间存在相关性。这些信号分子有望被认为是MDD诊断和预后的生物标志物,并可能为抑郁症的治疗提供新的药物靶点。在这里,我们回顾了一些FGF系统成员与抑郁症之间的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号